entertainment -WSS

entertainment

author：fashion 2025-10-01 20:14:34 - browse：112

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Eli Lilly reports tirzepatide MASH success during Q4 earnings

WSS

Tome Biosciences co

Bernie Sanders gets little from pharma CEOs on drug prices

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Roche's accidental data boosts hopes for anti

CDC says it’s too soon to assess risk posed by Covid subvariant

Why Eli Lilly’s earnings didn’t quite live up to the hype

hotspot

entertainment

focus

Wildfire smoke exposes gaps in outdoor worker protections

STAT Boddities: What happens to the brain when we get scared?

Peter Hotez and the public health issue of online harassment

Why don't Americans have at

Psychedelics group wrestles with new pharma identity

Health officials lay out plans to cope with respiratory virus season

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Boddities: What happens to the brain when we get scared?

In age of alternative facts, a scholarly course on calling out crap

Here’s what’s in the FDA plan to include pregnant women in clinical trials

focus

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Bernie Sanders gets little from pharma CEOs on drug prices

Bernie Sanders gets little from pharma CEOs on drug prices

Artificial intelligence use in health care faces greater scrutiny in 2024

Health officials lay out plans to cope with respiratory virus season

Wikipedia

Wikipedia

knowledge

hotspot